What antibiotic is given for bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic Treatment for Acute Bacterial Sinusitis

Amoxicillin is the first-line antibiotic of choice for uncomplicated acute bacterial sinusitis in situations where antimicrobial resistance is not suspected. 1, 2

Initial Antibiotic Selection

Standard First-Line Options:

  • For uncomplicated cases with no risk factors for resistance:
    • Amoxicillin: 45 mg/kg/day in 2 divided doses for children; 500 mg twice daily for adults 1, 2

For High-Risk Situations:

  • High-dose amoxicillin or amoxicillin-clavulanate is recommended when:
    • Patient is in a community with high prevalence of nonsusceptible S. pneumoniae (>10%) 1
    • Patient is younger than 2 years 1, 2
    • Patient attends child care 1
    • Patient has received antibiotics within the previous 4-6 weeks 1, 2
    • Dosage: 80-90 mg/kg/day of amoxicillin component in 2 divided doses (maximum 2g per dose) 1

For Penicillin-Allergic Patients:

  • Alternative options include:
    • Cephalosporins: cefuroxime, cefpodoxime, cefprozil, cefdinir 1
    • Macrolides: clarithromycin, azithromycin (in cases of serious drug allergy) 1, 3
    • Fluoroquinolones: reserved for treatment failures or complications 1

Specific Antibiotic Selection Based on Sinusitis Type

Maxillary Sinusitis:

  • First-line: Amoxicillin-clavulanate, 2nd and 3rd generation cephalosporins (except cefixime), or pristinamycin 1

Frontal, Ethmoidal, or Sphenoidal Sinusitis:

  • These are more serious and may require:
    • Amoxicillin-clavulanate, 2nd/3rd generation cephalosporins, or
    • Fluoroquinolones active against pneumococci (levofloxacin, moxifloxacin) 1

Treatment Duration

  • Standard duration is 7-10 days for most cases 1, 3
  • Some specific antibiotics have demonstrated efficacy in shorter courses:
    • Cefuroxime-axetil and cefpodoxime-proxetil have shown effectiveness in 5-day regimens 1
    • Levofloxacin has FDA approval for 5-day treatment at 750mg daily 4

Management of Treatment Failures

  • For partial response: Continue antibiotic treatment for another 10-14 days 1
  • For poor response to initial therapy:
    • Switch to high-dose amoxicillin-clavulanate, cefuroxime, cefpodoxime, cefprozil, or cefdinir 1
    • Consider adding anaerobic coverage with clindamycin or metronidazole for sinusitis failing to improve after 21-28 days of initial treatment 1

Common Pitfalls and Caveats

  • Antibiotic treatment of uncomplicated viral upper respiratory tract infections is inappropriate and strongly discouraged 1
  • High-dose amoxicillin-clavulanate may cause more severe diarrhea than standard-dose therapy (15.8% vs 4.8% in one study) 5
  • Recent research shows mixed results regarding benefits of high-dose vs. standard-dose amoxicillin-clavulanate, with one study showing no significant difference in efficacy 6
  • Bacterial resistance patterns vary geographically; practitioners should be familiar with local patterns of antimicrobial susceptibility 1, 2
  • Consider underlying factors in recurrent sinusitis cases, including allergies, immunodeficiency, and anatomical abnormalities 1

Microbiology and Resistance Considerations

  • The predominant pathogens in acute bacterial sinusitis are:
    • Streptococcus pneumoniae (10-15% nonsusceptible to penicillin) 1, 2
    • Haemophilus influenzae (10-42% β-lactamase positive) 1, 2
    • Moraxella catarrhalis (nearly 100% β-lactamase positive) 1, 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.